Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA · Real-Time Price · USD
32.28
-1.49 (-4.41%)
At close: Mar 3, 2026, 4:00 PM EST
33.46
+1.18 (3.66%)
Pre-market: Mar 4, 2026, 8:44 AM EST
Teva Pharmaceutical Employees
Teva Pharmaceutical Industries had 33,950 employees as of December 31, 2025. The number of employees decreased by 2,880 or -7.82% compared to the previous year.
Employees
33,950
Change (1Y)
-2,880
Growth (1Y)
-7.82%
Revenue / Employee
$508,336
Profits / Employee
$41,532
Market Cap
37.59B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 33,950 | -2,880 | -7.82% |
| Dec 31, 2024 | 36,830 | -1,021 | -2.70% |
| Dec 31, 2023 | 37,851 | 1,025 | 2.78% |
| Dec 31, 2022 | 36,826 | -711 | -1.89% |
| Dec 31, 2021 | 37,537 | -2,679 | -6.66% |
| Dec 31, 2020 | 40,216 | 177 | 0.44% |
| Dec 31, 2019 | 40,039 | -2,496 | -5.87% |
| Dec 31, 2018 | 42,535 | -9,257 | -17.87% |
| Dec 31, 2017 | 51,792 | -5,168 | -9.07% |
| Dec 31, 2016 | 56,960 | 14,072 | 32.81% |
| Dec 31, 2015 | 42,888 | -121 | -0.28% |
| Dec 31, 2014 | 43,009 | -1,936 | -4.31% |
| Dec 31, 2013 | 44,945 | -1,003 | -2.18% |
| Dec 31, 2012 | 45,948 | 194 | 0.42% |
| Dec 31, 2011 | 45,754 | 6,094 | 15.37% |
| Dec 31, 2010 | 39,660 | 4,571 | 13.03% |
| Dec 31, 2009 | 35,089 | -3,218 | -8.40% |
| Dec 31, 2008 | 38,307 | 10,395 | 37.24% |
| Dec 31, 2007 | 27,912 | 1,242 | 4.66% |
| Dec 31, 2006 | 26,670 | 11,972 | 81.45% |
| Dec 31, 2005 | 14,698 | 885 | 6.41% |
| Dec 31, 2004 | 13,813 | 2,853 | 26.03% |
| Dec 31, 2003 | 10,960 | 1,383 | 14.44% |
| Dec 31, 2002 | 9,577 | 591 | 6.58% |
| Dec 31, 2001 | 8,986 | 361 | 4.19% |
| Dec 31, 2000 | 8,625 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Takeda Pharmaceutical Company | 47,455 |
| Viatris | 30,000 |
| Dr. Reddy's Laboratories | 27,811 |
| Haleon | 24,561 |
| Zoetis | 14,500 |
| Elanco Animal Health | 9,900 |
| Alkermes | 2,050 |
| Neurocrine Biosciences | 2,000 |
TEVA News
- 4 hours ago - Billionaire Stanley Druckenmiller Dumped 2 of His Top Performers -- Teva and Taiwan Semiconductor -- and Made This Sector-Based ETF His Fund's New No. 2 Holding - The Motley Fool
- 22 hours ago - Baron Health Care Fund Q4 2025 Contributors And Detractors - Seeking Alpha
- 1 day ago - Eliyahu Kalif Sells 345,810 Shares of Teva Pharmaceutical Industries Ltd (TEVA) - GuruFocus
- 1 day ago - The Best Healthcare Stock to Invest $1,000 in Right Now - The Motley Fool
- 2 days ago - What's Driving the Market Sentiment Around Teva Pharmaceutical Industries Ltd? - Benzinga
- 4 days ago - Here's Why I Won't Touch Teva Pharmaceutical With a 10‑Foot Pole - The Motley Fool
- 5 days ago - Allspring Smid Cap Growth Fund Q4 2025 Top Contributors And Detractors - Seeking Alpha
- 7 days ago - Teva to Present at the Upcoming Investor Conferences in March - GlobeNewsWire